Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Bizact Tonsillectomy: Postoperative Pain, Bleeding and Cost-effectiveness (Randomized Study)

NCT: NCT07842419 · COMPLETED

NCT IDNCT07842419
StatusCOMPLETED
Start Date2021-03-01
Completion2025-12-31
SponsorHelsinki University Central Hospital (OTHER)
First posted
Last updated

Brief Summary

Randomized trial assessing Bizact-instrument in tonsillectomy and it's impact on postoperative recovery (pain, hemorrhage)

Frequently Asked Questions

What is Bizact Tonsillectomy: Postoperative Pain, Bleeding and Cost-effectiveness (Randomized Study)?

Bizact Tonsillectomy: Postoperative Pain, Bleeding and Cost-effectiveness (Randomized Study) is a clinical trial registered under NCT07842419. Current status: COMPLETED.

What is the status of NCT07842419?

The current status of NCT07842419 (Bizact Tonsillectomy: Postoperative Pain, Bleeding and Cost-effectiveness (Randomized Study)) is: COMPLETED.

When did Bizact Tonsillectomy: Postoperative Pain, Bleeding and Cost-effectiveness (Randomized Study) start?

Bizact Tonsillectomy: Postoperative Pain, Bleeding and Cost-effectiveness (Randomized Study) started on 2021-03-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑